Erratum: Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC (European Journal of Cardio-thoracic Surgery (2005) 27 (1092-1098) DOI: 10.1016/j.ejcts.2005.02.035);Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC

European Journal of Cardio-thoracic Surgery

Volumn 27, Issue 6, 2005, Pages 1092-1098

  Pezzetta, Edgardo ^a   Stupp, Roger ^b   Zouhair, Abderrahim ^b   Guillou, Louis ^b   Taffé, Patrick ^b   Von Briel, Christian ^c   Krueger, Thorsten ^a   Ris, Hans Beat ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Disease free survival; Induction therapy; NSCLC; Pathological nodal downstaging; Postoperative complications; Recurrence; Resectability rate; Sequential and concomitant radiochemotherapy; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOCETAXEL;

ABDOMINAL RADIOGRAPHY; ABDOMINAL SCINTISCANNING; ADJUVANT CHEMOTHERAPY; ADULT; AGED; BONE SCINTISCANNING; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MEDIASTINOSCOPY; MEDIASTINUM LYMPH NODE; METASTASIS; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 19344367424     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2005.06.029     Document Type: Erratum

References (25)

1. R. Rosell, J. Gomez-Codina, C. Camps, J. Maestre, J. Padille, A. Canto, J.L. Mate, S. Li, J. Roig, and A. Olazabal A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer N Engl J Med 330 1994 153 158
2. J.A. Roth, F. Fossella, R. Komaki, M.B. Ryan, J.B. Putnam Jr, J.S. Lee, H. Dhingra, L. De Caro, M. Chasen, and M. Mc Gavran A randomized trial comparing preoperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer J Natl Cancer Inst 86 1994 673 680
3. H.I. Pass, H.W. Pogrebniak, S.M. Steinberg, J. Mulshine, and J. Minna Randomized trial of neoadjuvant therapy for lung cancer: interim analysis Ann Thorac Surg 53 1992 992 998
4. French Thoracic Cooperative Group A. Depierre, B. Milleron, D. Moro-Sibilot, S. Chevret, E. Quoix, B. Lebeau, D. Braun, J.L. Breton, E. Lemarie, S. Gouva, N. Paillot, J.M. Bredot, H. Janicot, F.X. Lebas, P. Terrioux, J. Clavier, P. Foucher, M. Monchatre, D. Coetmoeur, M.C. Level, P. Leclerc, F. Blanchou, J.M. Rodier, L. Thiberville, A. Villeneuve, V. Westeel, and C. Chastang Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small cell lung cancer J Clin Oncol 20 2002 247 253
5. A. Spira, and D.S. Ettinger Multidisciplinary management of lung cancer N Engl J Med 350 2004 379 392
6. D.C. Betticher, S.F. Hsu Schmitz, M. Tötsch, E. Hauser, C. Joss, C. von Briel, R.A. Schmid, M. Pless, J. Habicht, A.D. Roth, A. Spiliopoulos, R. Stahel, W. Weder, R. Stupp, F. Egli, M. Furrer, H. Honegger, M. Wernli, T. Cerny, and H.B. Ris Mediastinal lymph node clearance after doxetacel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial J Clin Oncol 21 2003 1752 1759
7. J. Martin, R.J. Ginsberg, E.S. Venkatraman, M.S. Bains, R.J. Downey, R.J. Korst, M.G. Kris, and V.W. Rusch Long-term results of combined-modality therapy in resectable non-small cell lung cancer J Clin Oncol 20 2002 1989 1995
8. D.J. Adelstein, T.W. Rice, L.A. Rybicki, J.F. Greskovich Jr, J.P. Ciezki, M.A. Carrol, and M.M. De Camp Accelerated hyperfractionated radiation, concurrent paclitaxel/cisplatin chemotherapy and surgery for stage III non-small cell lung cancer Lung Cancer 36 2002 167 174
9. R. Bueno, W.G. Richards, S.J. Swanson, M.T. Jaklitsch, J.M. Lukanich, S.J. Mentzer, and D.J. Sugarbaker Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival Ann Thorac Surg 70 2000 1826 1831
10. N. Martini, M.G. Kris, B.J. Flehinger, R.J. Gralla, M.S. Bains, M.E. Burt, R. Helan, P.M. Mc Cormack, K.M. Pisters, J.R. Rigas, V.W. Rusch, and R.J. Ginsberg Preoperative chemotherapy for stage IIIA (N2) lung cancer: the Sloan-Kettering experience with 136 patients Ann Thorac Surg 55 1993 1365 1374
11. V.W. Rusch, K.S. Albain, J.J. Crowley, T.W. Rice, V. Lonchyna, R. Mc Kena Jr, R.B. Livingston, B.R. Griffin, and J.R. Benfield Surgical resection of stage IIIA and stage IIIB non- small cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group Trial J Thorac Cardiovasc Surg 105 1993 97 106
12. G.M. Strauss, J.E. Herndon, D.D. Sherman, D.J. Mathisen, R.W. Carey, N.C. Choi, V.B. Rege, C. Modeas, and M.R. Green Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study J Clin Oncol 10 1992 1237 1244
13. D.H. Grunenwald, F. Andre, C. Le Pechoux, P. Girard, C. Lamer, A. Laplanche, M. Tarayre, R. Arriagada, and T. Le Chevalier Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non-small cell lung cancer J Thorac Cardiovasc Surg 122 2001 796 802
14. V.W. Rusch, D.J. Giroux, M.J. Kraut, J. Crowley, M. Hazuka, D. Johnson, M. Goldberg, F. Detterbeck, F. Sheperd, R. Burkes, T. Winton, C. Deschams, R. Livingston, and D. Gandara Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160) J Thorac Cardiovasc Surg 121 2001 472 483
15. C.D. Wright, M.T. Menard, J.C. Wain, D.M. Donhaue, H.M. Grillo, T.J. Lynch, N.C. Choi, and D.J. Mathisen Induction chemoradiation compared with induction radiation for lung cancer involving the superior sulcus Ann Thorac Surg 73 2002 1541 1544
16. M.K. Widmer, T. Krueger, D. Lardinois, A. Banic, and H.B. Ris A compararative evaluation of intrathoracic latissimus dorsi and serratus anterior muscle transposition Eur J Cardiothorac Surg 18 2000 435 439
17. D. Lardinois, A. Horsch, T. Krueger, M. Dusmet, and H.B. Ris Mediastinal reinforcement after induction therapy and pneumonectomy: comparison of intercostal versus diaphragm flaps Eur J Cardiothorac Surg 21 2002 74 78
18. N. Martini Mediastinal lymph node dissection for lung cancer, techniques of pulmonary resection Chest Surg Clin N Am 5 1995 189 203
19. D. Lardinois, A. Schallberger, D. Betticher, and H.B. Ris Postinduction video-mediastinoscopy is as accurate and safe as video-mediastinoscopy in patients without pretreatment for potentially operable non-small cell lung cancer Ann Thorac Surg 75 2003 1102 1106
20. G. Veronesi, P.G. Solli, F. Leo, M. D'Aiuto, G. Pelosi, M.E. Leon, F. De Braud, L. Spaggiari, and U. Pastorino Low morbidity of bronchoplastic procedures after chemotherapy for lung cancer Lung Cancer 36 2002 91 97
21. E.A. Rendina, F. Venuta, T. De Giacomo, A.M. Ciccone, G. Ruvolo, G.F. Coloni, and C. Ricci Induction chemotherapy for T4 centrally located non-small cell lung cancer J Thorac Cardiovasc Surg 117 1999 225 233
22. A.J.H. Meyer, T. Krueger, D. Lepori, M. Dusmet, J.D. Aubert, P. Pasche, and H.B. Ris Closure of large intrathoracic airway defects using extrathoracic muscle flaps Ann Thorac Surg 77 2004 397 405
23. C. Doddoli, P. Thomas, X. Thirion, Y. Serée, R. Giudicelli, and P. Fuentes Postoperative complications in relation with induction therapy for lung cancer Eur J Cardiothorac Surg 20 2001 385 390
24. G. Stamatis, D. Djuric, W. Eberhardt, C. Pottken, G. Zaboura, S. Fechner, and T. Fujimoto Postoperative morbidity and mortality after induction chemoradiotherapy for locally advanced lung cancer: an analysis of 350 operated patients Eur J Cardiothorac Surg 22 2002 292 297
25. J. Martin, R.J. Ginsberg, A. Abolhoda, M.S. Bains, R.J. Downey, R.J. Korst, T.L. Weigel, M.G. Kris, E.S. Venkatraman, and V.W. Rusch Morbidity and mortality after neoadjuvant therapy for lung cancer. The risk of right pneumonectomy Ann Thorac Surg 72 2001 1149 1154